MARKET

TCMD

TCMD

Tactile Sys Tech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

48.67
-1.25
-2.50%
After Hours: 48.67 0 0.00% 16:00 03/03 EST
OPEN
49.42
PREV CLOSE
49.92
HIGH
50.45
LOW
47.59
VOLUME
171.66K
TURNOVER
--
52 WEEK HIGH
64.53
52 WEEK LOW
29.47
MARKET CAP
949.43M
P/E (TTM)
-1241.5816
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Sunesis Pharmaceuticals, Owens & Minor leads healthcare gainers; Rafael, Constellation Pharmaceuticals among major losers
Gainers: Sunesis Pharmaceuticals (SNSS) +38%, Owens & Minor OMI +32%, Salarius Pharmaceuticals SLRX +20%, Poseida Therapeutics (PSTX) +20%, PRA Health Sciences PRAH +19%.Losers: Rafael (RFL) -12%, Constellation Pharmaceuticals CNST -12%, Biofrontera AG (BF...
Seekingalpha · 02/24 15:59
--Analyst Actions: Oppenheimer Adjusts Tactile Systems Technology PT to $61 From $55, Maintains Outperform Rating
MT Newswires · 02/24 12:12
Analysts Offer Insights on Healthcare Companies: Tactile Systems Technology (TCMD) and Atricure (ATRC)
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tactile Systems Technology (TCMD) and Atricure (ATRC) with
SmarterAnalyst · 02/24 10:45
BTIG Remains a Buy on Tactile Systems Technology (TCMD)
In a report released yesterday, Ryan Zimmerman from BTIG maintained a Buy rating on Tactile Systems Technology (TCMD), with a price target of $60.00. The
SmarterAnalyst · 02/24 09:13
DJ Tactile Systems Technology, Inc. CEO Dan Reuvers on Q4 2020 Results -- Earnings Call Transcript >TCMD
Dow Jones · 02/24 03:59
BRIEF-Tactile Systems Reports Q4 EPS Of $0.61
reuters.com · 02/23 22:20
Recap: Tactile Systems Tech Q4 Earnings
Shares of Tactile Systems Tech (NASDAQ:TCMD) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 177.27% over the past year to $0.61, which beat the estimate of $0.24. Revenue of $59,200,000 high...
Benzinga · 02/23 22:18
Tactile Systems Technology EPS beats by $0.37, beats on revenue
Tactile Systems Technology (TCMD): Q4 GAAP EPS of $0.61 beats by $0.37.Revenue of $59.24M (+3.8% Y/Y) beats by $1.02M.2021 Outlook: Total revenue of $215.3-$224.5M, representing an increase of 15% to 20%
Seekingalpha · 02/23 21:43
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TCMD. Analyze the recent business situations of Tactile Sys Tech through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TCMD stock price target is 65.25 with a high estimate of 70.00 and a low estimate of 60.00.
EPS
Institutional Holdings
Institutions: 269
Institutional Holdings: 22.31M
% Owned: 114.38%
Shares Outstanding: 19.51M
TypeInstitutionsShares
Increased
51
949.19K
New
44
188.39K
Decreased
53
1.26M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-2.37%
Healthcare Equipment & Supplies
-2.63%
Key Executives
Chairman/Director
Peter Soderberg
President/Chief Executive Officer/Director
Daniel Reuvers
Chief Financial Officer
Brent Moen
Senior Vice President/Director of Sales
Bryan Rishe
Chief Human Resource Officer
Juleen Krings
Chief Information Officer
Peter Schaubach
Vice President
Jay Stracke
Director
Sheri Dodd
Director
Deepti Jain
Independent Director
William Burke
Independent Director
Raymond Huggenberger
Independent Director
Richard Nigon
Independent Director
Cheryl Pegus
Independent Director
Kevin Roche
  • Dividends
  • Splits
  • Insider Activity
No Data
About TCMD
Tactile Systems Technology, Inc. is a medical technology company that develops and provides medical devices for the treatment of chronic diseases at home. The Company is a manufacturer and distributor of the Flexitouch and Entre Systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch System, a medical device used to treat venous leg ulcers and chronic venous insufficiency. Its products deliver long-term treatment of chronic diseases. The Company provides its products for use in the home and sells them through vascular, wound and lymphedema clinics throughout the United States. The Company offers a platform to deliver at-home healthcare solutions throughout the United States. Its initial area of therapeutic focus is vascular disease, with a focus on advancing the care in treating lymphedema and chronic venous insufficiency.

Webull offers kinds of Tactile Systems Technology Inc stock information, including NASDAQ:TCMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TCMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TCMD stock methods without spending real money on the virtual paper trading platform.